Harada N[au] - Search Results

Year	Number of Results
1957	2
1958	3
1959	1
1960	1
1961	1
1962	4
1963	2
1964	14
1965	5
1966	4
1967	4
1968	6
1969	3
1970	2
1971	2
1972	2
1974	5
1975	5
1976	2
1977	4
1978	5
1979	2
1980	6
1981	8
1982	10
1983	10
1984	16
1985	14
1986	10
1987	22
1988	22
1989	17
1990	32
1991	21
1992	33
1993	35
1994	37
1995	37
1996	39
1997	48
1998	42
1999	54
2000	52
2001	58
2002	84
2003	62
2004	88
2005	78
2006	68
2007	82
2008	96
2009	72
2010	80
2011	83
2012	83
2013	72
2014	90
2015	77
2016	90
2017	78
2018	78
2019	79
2020	109
2021	113
2022	72
2023	1

1

Consequences of visiting restrictions during the COVID-19 pandemic: An integrative review.

Hugelius K, Harada N, Marutani M. Hugelius K, et al. Among authors: harada n. Int J Nurs Stud. 2021 Sep;121:104000. doi: 10.1016/j.ijnurstu.2021.104000. Epub 2021 Jun 12. Int J Nurs Stud. 2021. PMID: 34242976 Free PMC article. Review.

2

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1.

Ogitani Y, Aida T, Hagihara K, Yamaguchi J, Ishii C, Harada N, Soma M, Okamoto H, Oitate M, Arakawa S, Hirai T, Atsumi R, Nakada T, Hayakawa I, Abe Y, Agatsuma T. Ogitani Y, et al. Among authors: harada n. Clin Cancer Res. 2016 Oct 15;22(20):5097-5108. doi: 10.1158/1078-0432.CCR-15-2822. Epub 2016 Mar 29. Clin Cancer Res. 2016. PMID: 27026201

3

Engineering hybrid exosomes by membrane fusion with liposomes.

Sato YT, Umezaki K, Sawada S, Mukai SA, Sasaki Y, Harada N, Shiku H, Akiyoshi K. Sato YT, et al. Among authors: harada n. Sci Rep. 2016 Feb 25;6:21933. doi: 10.1038/srep21933. Sci Rep. 2016. PMID: 26911358 Free PMC article.

4

Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance.

Muraoka D, Seo N, Hayashi T, Tahara Y, Fujii K, Tawara I, Miyahara Y, Okamori K, Yagita H, Imoto S, Yamaguchi R, Komura M, Miyano S, Goto M, Sawada SI, Asai A, Ikeda H, Akiyoshi K, Harada N, Shiku H. Muraoka D, et al. Among authors: harada n. J Clin Invest. 2019 Mar 1;129(3):1278-1294. doi: 10.1172/JCI97642. Epub 2019 Feb 11. J Clin Invest. 2019. PMID: 30628894 Free PMC article.

5

Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.

Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, Hida E. Kario K, et al. Among authors: harada n. Eur Heart J. 2021 Oct 21;42(40):4111-4122. doi: 10.1093/eurheartj/ehab559. Eur Heart J. 2021. PMID: 34455443 Free PMC article. Clinical Trial.

6

Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma.

Takakuwa T, Okayama Y, Nakamae H, Kuno M, Makuuchi Y, Harada N, Okamura H, Nishimoto M, Nakashima Y, Koh H, Hino M. Takakuwa T, et al. Among authors: harada n. Ann Hematol. 2022 Jul;101(7):1609-1610. doi: 10.1007/s00277-022-04803-0. Epub 2022 Feb 26. Ann Hematol. 2022. PMID: 35218398 No abstract available.

7

Retraction notice to "Stimulation of sensory neurons by capsaicin increases tissue levels of IGF-I, thereby reducing reperfusion-induced apoptosis in mice" [Neuropharmacology, 52 (2007) 1303-1311].

Harada N, Okajima K, Kurihara H, Nakagata N. Harada N, et al. Neuropharmacology. 2022 Jan 1;202:108882. doi: 10.1016/j.neuropharm.2021.108882. Epub 2021 Nov 11. Neuropharmacology. 2022. PMID: 34774329 No abstract available.

8

Clinical effects and immune modulation of biologics in asthma.

Harada N, Ito J, Takahashi K. Harada N, et al. Respir Investig. 2021 Jul;59(4):389-396. doi: 10.1016/j.resinv.2021.03.003. Epub 2021 Apr 20. Respir Investig. 2021. PMID: 33893067 Review.

9

Impact of Capicua on Pancreatic Cancer Progression.

Yoshiya S, Itoh S, Yoshizumi T, Yugawa K, Kurihara T, Toshima T, Harada N, Hashisako M, Yonemasu H, Fukuzawa K, Oda Y, Mori M. Yoshiya S, et al. Among authors: harada n. Ann Surg Oncol. 2021 Jun;28(6):3198-3207. doi: 10.1245/s10434-020-09339-z. Epub 2020 Nov 20. Ann Surg Oncol. 2021. PMID: 33216264

10

Green-to-UV photon upconversion enabled by new perovskite nanocrystal-transmitter-emitter combination.

Koharagi M, Harada N, Okumura K, Miyano J, Hisamitsu S, Kimizuka N, Yanai N. Koharagi M, et al. Among authors: harada n. Nanoscale. 2021 Dec 13;13(47):19890-19893. doi: 10.1039/d1nr06588b. Nanoscale. 2021. PMID: 34846408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results